Finland· FI-REL-REL14137
Riamet
A artemether and lumefantrine product containing artemether + lumefantrinum, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Artemether and lumefantrine is registered in 7 of 19 countries.
Countries holding a registration under ATC P01BF01 (artemether and lumefantrine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Artemether and lumefantrine · ATC P01BF01
7 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of artemether and lumefantrine costs, country by country.
Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Artemether and lumefantrine · price per daily dose (0.28 g)
USD · FX 28 Sept 2026
- CH Switzerland$19.10
The record
At a glance
Fimea (Finland)- Active substance
- Artemether + Lumefantrinum
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- P01BF01
- ATC class
- Artemether and lumefantrine
- Defined daily dose
- 0.28 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for artemether and lumefantrine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Artemether and lumefantrine · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Artemether and lumefantrine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRiamet 20 mg/120 mg, TablettenNovartis Pharma Schweiz AG
- GermanyRiametNovartis Pharma Gmbh
- SpainRIAMET 20 mg/120 mg COMPRIMIDOSNovartis Farmaceutica S.A.
- FranceRIAMET 20 mg/120 mg, compriméNOVARTIS PHARMA
- United KingdomRiamet tabletsNovartis Pharmaceuticals UK Ltd
- NetherlandsRiamet 20 mg/120 mg, tablettenNovartis Pharma B.V.
- NorwayRiametNovartis (2)
- SwedenRiamet 20 mg/120 mg TablettNovartis Sverige AB
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Riamet
- Belgium · Riamet
- Germany · Riamet
- France · Riamet
- United Kingdom (Northern Ireland) · Riamet
- Netherlands · Riamet
- Portugal · Airalam, Artemeter + Lumefantrina Phagecon
- Sweden · Riamet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1896fef8-c0ac-4f1c-973a-572bfdbb53ed GET /v1/drugs/1896fef8-c0ac-4f1c-973a-572bfdbb53ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "artemeetteri ja lumefantriini",
"ma_number": "16059",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL14137",
"authorised_at": "2001-01-15"
}See everything about artemether and lumefantrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.